Insights

Unveiling Expert Insights
for Healthcare Compliance

At Safe Harbor Group, our experts are dedicated to providing invaluable insights that help healthcare providers navigate complex regulatory environments with confidence. Our deep knowledge and experience empower you to make informed decisions that protect your practice from compliance risks and ensure long-term success.

CMS Withdraws Final Skin Substitute LCDs

CMS Withdraws Final Skin Substitute LCDs; 2026 Oversight and Payment Reforms Remain the Operative...

FDA’s Overreach on Compounded Peptides: Legal Battles and How Clinics Can Push Back

Introduction: Peptide therapies like BPC-157, TB-500 (Thymosin Beta-4), CJC-1295, and other short proteins have...

WOUND CARE UPDATE: CY 2026 Medicare Physician Fee Schedule Final Rule (CMS1832F)

Published November 5, 2025 • Effective January 1, 2026 This update explains the new...

Advanced Wound Care Products, Big Medicare Dollars, and the Kickback Trap

From audits resulting in significant overpayment demands, to indictments for alleged violations of the...

FDA’s “Held for Sale” Interpretation: Device Reuse in Physician Offices and FDCA Liability

Practicing and hospital-based physicians may be surprised to learn that the Federal Food, Drug,...

False Claims Act Statistical Sampling & Extrapolation: Case Law and Guidance

Statistical sampling and extrapolation are methods used by the Office of Inspector General (OIG)...

Legal Preparedness in Healthcare: Drug Diversion Insights Podcast

Safe Harbor Group President Ronald Chapman II was featured on the Drug Diversion Insights...

Compliance & Healthcare Fraud: The Pain Unfiltered Podcast

SHG Healthcare President Ronald Chapman II was featured on the Pain Unfiltered Podcast, hosted...

SHG Founder Discusses Federal Investigations

SHG Healthcare President Ronald Chapman II appears on White Collar Advice SHG Healthcare President...

SHG Founder on Becker’s Healthcare Podcast to Discuss Healthcare Fraud Investigations

SHG Founder Ronald Chapman II, Esq., LLM, sits down with Becker’s Healthcare Podcast to...

SHG Founder Discusses Physician Requirements for Legal Preparedness

SHG Healthcare President Ronald Chapman II recently appeared on The Podcast by Kevin MD...

SHG Founder Discusses Healthcare Law

SHG Healthcare President Ronald Chapman II discusses healthcare law with Dr. Chadi Nabhan on...

CMS Withdraws Final Skin Substitute LCDs

CMS Withdraws Final Skin Substitute LCDs; 2026 Oversight and Payment Reforms Remain the Operative...

WOUND CARE UPDATE: CY 2026 Medicare Physician Fee Schedule Final Rule (CMS1832F)

Published November 5, 2025 • Effective January 1, 2026 This update explains the new...

DEA’s Proposed Telemedicine Rules: What Doctors Need to Know (and Why It Might Get Complicated)

By Ronald W. Chapman II, Safe Harbor Group The Drug Enforcement Administration (DEA) has...

The McKinsey Case: A Wake-Up Call

McKinsey, one of the most prestigious consulting firms in the world, got tangled up...

Breaking Down the Overrule of Chevron: What It Means for Healthcare Providers

This article is written by SHG President, Ronald Chapman II In a recent ruling,...

DOJ Investigation into Done Global Inc.:Telemedicine Adderall Provider UnderScrutiny

Introduction Done Global Inc., is a prominent telehealth provider specializing in ADHD treatment. The...

CMS Withdraws Final Skin Substitute LCDs

CMS Withdraws Final Skin Substitute LCDs; 2026 Oversight and Payment Reforms Remain the Operative...

FDA’s Overreach on Compounded Peptides: Legal Battles and How Clinics Can Push Back

Introduction: Peptide therapies like BPC-157, TB-500 (Thymosin Beta-4), CJC-1295, and other short proteins have...

WOUND CARE UPDATE: CY 2026 Medicare Physician Fee Schedule Final Rule (CMS1832F)

Published November 5, 2025 • Effective January 1, 2026 This update explains the new...

Advanced Wound Care Products, Big Medicare Dollars, and the Kickback Trap

From audits resulting in significant overpayment demands, to indictments for alleged violations of the...

FDA’s “Held for Sale” Interpretation: Device Reuse in Physician Offices and FDCA Liability

Practicing and hospital-based physicians may be surprised to learn that the Federal Food, Drug,...

False Claims Act Statistical Sampling & Extrapolation: Case Law and Guidance

Statistical sampling and extrapolation are methods used by the Office of Inspector General (OIG)...

Top 10 Dirty Tricks Federal Investigators Use to Generate Evidence: A Deep Dive into Deception

Top 10 Dirty Tricks Federal Investigators Use to Generate Evidence: A Deep Dive into...

Why TikTok’s Survival Matters: The New Law That Threatens the 1st Amendment

The Protecting Americans from Foreign Adversary Controlled Applications Act (PFACAA) is a tyrannical law...

Top DOJ Enforcement Risks for Small to Mid-Sized Businesses in 2025

Navigating the shifting regulatory landscape in 2025 can be daunting for small to mid-sized...

DOGE Plan Released: The no-nonsense breakdown for business owners in Healthcare and Finance

Ron Chapman is a Federal Defense Attorney and Author of Unraveling Federal Criminal Investigations....

FDA’s Overreach on Compounded Peptides: Legal Battles and How Clinics Can Push Back

Introduction: Peptide therapies like BPC-157, TB-500 (Thymosin Beta-4), CJC-1295, and other short proteins have...

WOUND CARE UPDATE: CY 2026 Medicare Physician Fee Schedule Final Rule (CMS1832F)

Published November 5, 2025 • Effective January 1, 2026 This update explains the new...

Advanced Wound Care Products, Big Medicare Dollars, and the Kickback Trap

From audits resulting in significant overpayment demands, to indictments for alleged violations of the...

FDA’s “Held for Sale” Interpretation: Device Reuse in Physician Offices and FDCA Liability

Practicing and hospital-based physicians may be surprised to learn that the Federal Food, Drug,...

False Claims Act Statistical Sampling & Extrapolation: Case Law and Guidance

Statistical sampling and extrapolation are methods used by the Office of Inspector General (OIG)...

How Local Coverage Determinations (LCDs) Should Be Handled as Evidence Under the Bondi Administration

The weight of Local Coverage Determinations (LCDs) in False Claims Act (FCA) litigation has...

Safe Harbor Group: A Nationally Trusted Healthcare Compliance Partner

With a national presence and two headquarters in Metro Detroit and Washington D.C., Safe Harbor Group is dedicated to serving healthcare organizations across the U.S. Our team of compliance experts is here to meet your unique needs, providing support wherever you’re located.